- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 407/14 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group containing three or more hetero rings
Patent holdings for IPC class C07D 407/14
Total number of patents in this class: 1152
10-year publication summary
|
58
|
56
|
93
|
108
|
68
|
62
|
63
|
73
|
48
|
8
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| LG Chem, Ltd. | 17778 |
34 |
| Merck Patent GmbH | 5743 |
30 |
| Bristol-myers Squibb Company | 4817 |
26 |
| Novartis AG | 10467 |
24 |
| Pfizer Inc. | 3383 |
18 |
| Rohm and Haas Electronic Materials Korea Ltd. | 333 |
18 |
| Duk San Neolux Co., Ltd. | 676 |
15 |
| Boehringer Ingelheim International GmbH | 4571 |
14 |
| Janssen Pharmaceutica N.V. | 3287 |
14 |
| Astex Therapeutics Limited | 228 |
14 |
| Eisai R&D Management Co., Ltd. | 1193 |
14 |
| Samsung Display Co., Ltd. | 37493 |
13 |
| Celgene Corporation | 1398 |
13 |
| LT Materials Co., Ltd. | 427 |
13 |
| F. Hoffmann-La Roche AG | 7874 |
12 |
| Idemitsu Kosan Co., Ltd. | 4223 |
12 |
| Takeda Pharmaceutical Company Limited | 2728 |
12 |
| Hoffmann-La Roche Inc. | 3646 |
9 |
| Bayer Cropscience AG | 1933 |
9 |
| Gilead Sciences, Inc. | 2161 |
9 |
| Other owners | 829 |